Mangoceuticals (MGRX) Institutional Ownership → AI finds its first serious application (From Wall Street Star) (Ad) Free MGRX Stock Alerts $0.28 +0.02 (+6.99%) (As of 01:40 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Mangoceuticals (NASDAQ:MGRX)CurrentInstitutional OwnershipPercentage56.72%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$113.64KNumber ofInstitutional Sellers(last 12 months)0 Get MGRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Mangoceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Mangoceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/8/2023Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216% 7/28/2023Independent Advisor Alliance26,000$48K0.0%N/A0.162% (Data available from 1/1/2016 forward) MGRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MGRX shares? During the previous two years, the following institutional investors and hedge funds held shares of Mangoceuticals shares: Colonial River Wealth Management LLC ($66K), Independent Advisor Alliance ($48K).Learn more on MGRX's institutional investors. What percentage of Mangoceuticals stock is owned by institutional investors? 56.72% of Mangoceuticals stock is owned by institutional investors. Learn more on MGRX's institutional investor holdings. Which institutional investors have been buying Mangoceuticals stock? The following institutional investors have purchased Mangoceuticals stock in the last 24 months: Colonial River Wealth Management LLC ($36.10K), and Independent Advisor Alliance ($26K). How much institutional buying is happening at Mangoceuticals? Institutional investors have bought a total of 62,100 shares in the last 24 months. This purchase volume represents approximately $113.64K in transactions. Related Companies: BRTX Major Shareholders OTRK Major Shareholders SONX Major Shareholders CELZ Major Shareholders ENVB Major Shareholders CVKD Major Shareholders HSCS Major Shareholders ADIL Major Shareholders KZIA Major Shareholders TENX Major Shareholders This page (NASDAQ:MGRX) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mangoceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
